Company profile
Roche Glycart company profile
Roche Glycart develops antibody drug candidates, which include GA101, a humanized anti-CD20 monoclonal antibody to increase direct- and immune-mediated target cell death; and GA201, a humanized glycoengineered antibody for solid tumors.
Business identity
- Phone number
- +41447556161
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Founded
- 2000-01-01, Year
Headquarters
- Headquarters
- Schlieren, Zurich, Switzerland
- Postal code
- CH-8952
- Country code
- CH
- Continent
- Europe